loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X

Approved Drug Products containing 20505 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 JANSSEN PHARMS (6)

filter

01 TABLET;ORAL (6)

filter

01 DISCN (2)

02 RX (4)

filter

01 TOPAMAX (6)

filter

01 No (2)

02 Yes (4)

URL Supplier Web Content
TABLET; ORAL
300MG
1996-12-24
20505
TOPAMAX
DISCN
No
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET; ORAL
100MG
1996-12-24
20505
TOPAMAX
RX
Yes
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET; ORAL
400MG
1996-12-24
20505
TOPAMAX
DISCN
No
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET; ORAL
25MG
1996-12-24
20505
TOPAMAX
RX
Yes
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET; ORAL
200MG
1996-12-24
20505
TOPAMAX
RX
Yes
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET; ORAL
50MG
1996-12-24
20505
TOPAMAX
RX
Yes
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 20505

Looking for FDA Orange Book APPLICATION 20505 6

19

Johnson & Johnson Innovative Medicine, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is TOPIRAMATE, with a corresponding application number 20505.

Regulatory Information DISCN

With a dosage strength 300MG

Dosage Form Route TABLET; ORAL

Reference Listed Drug No

Approved since 1996-12-24

18

Johnson & Johnson Innovative Medicine, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is TOPIRAMATE, with a corresponding application number 20505.

Regulatory Information RX

With a dosage strength 100MG

Dosage Form Route TABLET; ORAL

Reference Listed Drug Yes

Approved since 1996-12-24

Therapeutic Equivalence (TE) Code AB

17

Johnson & Johnson Innovative Medicine, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is TOPIRAMATE, with a corresponding application number 20505.

Regulatory Information DISCN

With a dosage strength 400MG

Dosage Form Route TABLET; ORAL

Reference Listed Drug No

Approved since 1996-12-24

16

Johnson & Johnson Innovative Medicine, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is TOPIRAMATE, with a corresponding application number 20505.

Regulatory Information RX

With a dosage strength 25MG

Dosage Form Route TABLET; ORAL

Reference Listed Drug Yes

Approved since 1996-12-24

Therapeutic Equivalence (TE) Code AB

15

Johnson & Johnson Innovative Medicine, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is TOPIRAMATE, with a corresponding application number 20505.

Regulatory Information RX

With a dosage strength 200MG

Dosage Form Route TABLET; ORAL

Reference Listed Drug Yes

Approved since 1996-12-24

Therapeutic Equivalence (TE) Code AB

14

Johnson & Johnson Innovative Medicine, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is TOPIRAMATE, with a corresponding application number 20505.

Regulatory Information RX

With a dosage strength 50MG

Dosage Form Route TABLET; ORAL

Reference Listed Drug Yes

Approved since 1996-12-24

Therapeutic Equivalence (TE) Code AB

Post Enquiry
POST ENQUIRY